ArticleJournal of hepatocellular carcinoma2026
Development and Validation of a LASSO-RF-Cox-Derived Nomogram Incorporating Inflammatory Markers to Predict Long-Term Survival in Early-Stage Hepatocellular Carcinoma After Microwave Ablation.
Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to identify factors influencing overall survival (OS) in patients with hepatocellular carcinoma (HCC) undergoing microwave ablation (MWA) and to develop and validate a nomogram for predicting 3‑, 5‑, and 8‑year OS. Materials and Methods: Data from 440 patients who received MWA at Beijing Ditan Hospital, Captical Medical University were analyzed using least absolute shrinkage and selection operator (LASSO) regression, random forest (RF), and multivariable Cox regression to identify independent prognostic factors. A prognostic nomogram was constructed and validated. OS was assessed using Kaplan-Meier curves. Results: The variables selected by both LASSO and RF were incorporated into a multivariable Cox regression model, which identified tumor number, tumor size, monocyte-to-lymphocyte ratio (MLR), white blood cell count (WBC), and diabetes as independent risk factors for OS. The predictive accuracy, reliability, and clinical utility of the model were confirmed through Harrell's concordance index (C-index), time-dependent area under the receiver operating characteristic curve (AUC) analysis, calibration curves, and decision curve analysis (DCA). Furthermore, risk stratification based on the model effectively differentiated patients into distinct prognostic subgroups. Conclusion: A nomogram based on LASSO-RF-Cox analysis was developed to predict OS in early-stage HCC patients after MWA. The model demonstrated acceptable predictive performance in internal validation, with moderate discriminative ability. This model may help identify high-risk individuals and facilitate clinical decision-making, particularly in primary care settings due to its simple and readily available predictors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.